Project Grant R56DA059552
Award Date
9/1/24
Completion Date
8/31/25
Dollars Obligated
$375K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This $4.9 million project grant from the National Institutes of Health's National Institute on Drug Abuse will support research at The Johns Hopkins University from April 2022 to March 2026. The grant is part of the Drug Abuse and Addiction Research Programs (CFDA 93.279), which aims to develop new knowledge around prevention, diagnosis, treatment and causes of drug abuse and addiction. Specifically, the university will leverage rare longitudinal social and spatial network data along with...
This $1,210,300 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of novel polyvalent HIV vaccines designed to prevent intravenous transmission in people who inject drugs (PWID). The research team at Beth Israel Deaconess Medical Center, Inc. (BIDMC) will create diverse HIV envelope-based vaccines and evaluate their ability to rapidly clear multiple viral strains in animal models, with...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop effective methods for disseminating scientific evidence to policymakers in order to improve access to services that can prevent HIV transmission and overdose among people who use drugs. The $2,362,500 award, effective July 1, 2025 through June 30, 2029, will be administered by the University of California, Los Angeles...
The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $460,432 Project Grant to the Regents of the University of Minnesota to develop and pilot a comprehensive telehealth program at syringe service programs (SSPs) to engage people who inject drugs (PWID) into the HIV care continuum. The key products and services to be delivered include: Conducting formative research to understand determinants of HIV and addiction among...
This Project Grant award of $1,422,136 from the National Institutes of Health (CFDA 93.310 Trans-NIH Research Support) to Yale University aims to develop and evaluate novel methods to predict, detect, and diagnose outbreaks of HIV and other infectious diseases among people who use drugs. The key products and services to be delivered under this 5-year grant include: Developing modeling and pattern-recognition frameworks to predict jurisdictions at high risk of incipient infectious disease...
This federal Project Grant award, with ID R01DA059503, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,192,612 grant will fund a 5-year research project by The Miriam Hospital, a non-profit healthcare and research institution in Providence, RI, to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives of this multidisciplinary research...
This Project Grant award of $197,035 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year study to design and evaluate a community-based intervention to engage men who use alcohol and substances in HIV prevention services in rural South Africa. The primary objectives are to: 1) explore perceptions and preferences for HIV prevention services among men who frequent local bars (shebeens), 2) develop an intervention...
This federal Project Grant award of $1,365,212 from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) aims to optimize and test a peer-led dynamic choice HIV prevention intervention to increase coverage of biomedical prevention products among women at elevated HIV risk in southwestern Uganda. The project will refine the existing Search Dynamic Choice HIV Prevention (DCP) intervention to further engage women working in venues where transactional sex is...
The National Institute on Drug Abuse (NIDA) awarded a $873,784 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Arizona State University (ASU) to develop and pilot test an intervention called Project Vuselela (PV). PV integrates peer navigation and family engagement to improve antiretroviral therapy (ART) adherence and opioid substitution therapy (OST) continuation among people who inject drugs (PWID) in Johannesburg, South Africa. The project aims to build...
The National Institute on Drug Abuse (NIDA) awarded a Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $3,086,472 to the University of Rhode Island on September 15, 2024. The objective of this 5-year project is to evaluate the spillover effects of HIV interventions among marginalized populations, particularly young Black men who have sex with men (BMSM), who use illicit substances. The project will leverage data from three existing network studies in Chicago,...